I’m in favor of cycling infrastructure in the US, but it’s important to remember that the latitude of the Netherlands (like most of the European cycling cities) is north of the entire continental US.
I’m in decent shape, but will sweat at a resting heart rate in a Southern US summer.
So glad you enjoyed "On the Metal"! Your suggestion is a great one, and we'll work on this over the next few weeks; stay tuned, and in the meantime, enjoy the "Oxide and Friends" back catalog!
Second that! I was a big fan of "On the Metal", and was bummed when it ended. Stumbled upon "Oxide and Friends" almost by chance, and was happy to discover it kept the same style (and even better, with more voices).
You made my commute a lot more enjoyable. Still going through the old catalog -- the episode about NeXT and Objective-C (S1E8 July 5, 2021 [1]) was excellent.
It starts with researchers convincing their ethical review board that they should be given the opportunity to experiment with the different approach.
That’s why new procedures almost always are done on patients who are as good as dead (gene editing to change one’s hair color won’t soon get past ethical review, for example, but if gene editing gets used in mainstream medicine, enough data may be collected to make a review board say it’s acceptable to give it a try)
The first experiments typically only prove the medicine or procedure works. Long term survival of the patient the exception. From there, it’s step by step towards treating healthier and healthier patients.
If it turns out the approach is better for the typical patient, patient groups (who may even have paid for part of the research) start lobbying for its use. If the new procedure is both better and cheaper, insurers also will lobby for it.
Unfortunately, the recent proposal specifically reassures commercial banks that any US CBDC will be intermediated (right on page 2) [1]. Board of Governors can't risk jeopardizing their speaking fees.
Individual FedAccounts via USPS locations is the way to go for the underbanked [2]. But, disappointingly, this is not that.
reply